Position
Chief Financial Officer
Company
IRulya Therapeutics
Description
IRulya Therapeutics announced a management transition with Brigette Roberts being appointed as chief executive officer, John Militello as chief financial officer, and Keith Fandrick as chief operating officer. This change follows the company's corporate rebranding from Quince Therapeutics.
Quick answer
IRulya Therapeutics Appoints Brigette Roberts as Chief Executive Officer (October 30, 2026).
- What did IRulya Therapeutics announce on October 30, 2026?
- IRulya Therapeutics announced a management transition with Brigette Roberts being appointed as chief executive officer, John Militello as chief financial officer, and Keith Fandrick as chief operating officer. This change follows the company's corporate rebranding from Quince Therapeutics.
- What does IRulya Therapeutics do?
- IRulya Therapeutics, formerly known as Quince Therapeutics, is focused on developing LAM-001, a once-daily dry-powder inhaled formulation of rapamycin.
- Which similar companies made leadership changes around the same time?
- United Theranostics (October 29, 2026), Celea Therapeutics (October 29, 2026), Harmony Biosciences (October 30, 2026) and Gain Therapeutics (October 28, 2026) also announced leadership changes within 45 days of IRulya Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- United Theranostics Appoints Amber Woodward-Smith as Chief Financial Officer (October 29, 2026)
- Celea Therapeutics Appoints Paul Audhya as Chief Medical Officer (October 29, 2026)
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
- Gain Therapeutics Appoints Jeanette Weidner as Vice President of Finance (October 28, 2026)
- Adial Pharmaceuticals names Julie Saiki Chief Strategy Officer (October 31, 2026)
- NovaBridge Appoints Chuck as Chief Executive Officer (October 28, 2026)
Who to call at IRulya Therapeutics, and when
A new leader at IRulya Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day IRulya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IRulya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IRulya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IRulya Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
IRulya Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.